Michael S. Gilmore

Michael S. Gilmore is the Sir William Osler Professor of Ophthalmology at the Massachusetts Eye and Ear Infirmary, affiliated with Harvard Medical School. His research focuses on bacterial pathogenesis, antibiotic resistance mechanisms, and ocular microbiology. Key areas of study include Enterococcus species, surface biogeography of ocular infections, and genomic epidemiology. Gilmore leads NIH-funded projects investigating antibiotic resistance determinants and ocular tropism. He has authored over 287 publications, with recent work on gene cluster evolution, novel antimicrobial discovery, and bacterial diversity.

Education details are not explicitly stated in the text, but his involvement with Harvard Medical School suggests academic training in microbiology or ophthalmology. His grants include R21AI169730 (2022-2025) and R01EY031600 (2020-2025), focusing on β-lactam resistance and ocular surface microbiota. No awards are mentioned here.

Research interests span Enterococcus biology, antibiotic susceptibility, and ocular infection dynamics. His lab (Howe Lab) collaborates broadly, with studies on lantibiotics, genome mining in marine-associated bacteria, and synthetic retinoid antibiotics. He has advised numerous co-authors but specific student names are not listed.

Grants and projects emphasize translational research, such as developing diagnostics for intraocular pathogens and studying liver disease-linked Enterococcus carcinogenesis. His work bridges clinical ophthalmology with microbiological and genomic approaches.